Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "BioMedical Resources" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about BioMedical Resources for you to read. Along with our medical data and news we also list BioMedical Resources Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioMedical Resources Companies for you to search.
David Raths, Contributing EditorThe National Institutes of Health has launched an initiative to give NIH biomedical researchers access to the most advanced commercial cloud computing resources.
(The Mount Sinai Hospital / Mount Sinai School of Medicine) The National Institutes of Health (NIH) have awarded $6.5 million to a consortium that includes the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai, to establish the Center for Reproducible Biomedical Modeling. The multi-institution biomedical technology resource center will accelerate th...
Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, and DSM Biomedical a global solutions provider in biomedical science and regenerative medicine, today reported that they have expanded ...
Applications are invited from specialist biomedical service companies who meet the criteria detailed in the award application form available at http://www.bionow.co.uk/events/bionowannualawardsdinner.aspx. The new award complements the award categories already announced and detailed below and highlights the breadth and strength of the offering of the biomedical cluster across the North.Biomed...
AIVITA Biomedical has enrolled the first patient in its Phase II clinical trial to evaluate AV-GBM-1 for the treatment of...Read More... The post AIVITA Biomedical enrols first patient in AV-GBM-1 trial appeared first on Drug Development Technology.
Capillary Biomedical has closed a round of seed financing led by Cove Fund, generating $2.9 million in proceeds. -More-
Aerie Pharmaceuticals has secured an exclusive global license to DSM Biomedical's polyesteramide polymer technology for any n -More-
The Biomedical Innovation Hub is a brand new, fully serviced biomedical laboratory specifically designed to provide entrepreneurs and innovative start-ups with access to affordable laboratory facilities and equipment. During BioTrinity, Helen Miller-Viney, Business Development Manager, explained to Fintan Walton how this facility will provide laboratory space and guidance for start-up companies a...
Texas-based Brazos Biomedical, an American Diversified Holdings unit, is in talks with institutional investors to create a st -More-
Bionow is urging companies and individuals across the North of England to nominate their outstanding achievements for the prestigious 2014 Biomedical Awards.The Awards, now in its 2nd year will take place on Thursday 24 April 2014, at the BALTIC Centre for Contemporary Art, on Gateshead Quays. The event will celebrate the strength and depth of the cluster and the diversity of the companies w...
(World Scientific) World Scientific's latest guide, The 21st Century Guide to Writing Articles in the Biomedical Sciences, leads readers through the writing of articles in the biomedical sciences. The book is exactly what its name suggests: a contemporary, user-friendly, pocket-sized-yet-thorough journal article writing guide. The guide is tailored to the needs of young professionals who conduct r...
Boston Biomedical has dosed the first patient in a Phase l clinical trial to test the safety and pharmacokinetic of...Read More... The post Boston Biomedical doses first patient in Phase l trial of DSP-0509 appeared first on Drug Development Technology.
AIVITA Biomedical has dosed the first two patients in its Phase II clinical trial of AV-GBM-1 to treat patients with...Read More... The post AIVITA Biomedical doses first patients in Phase II AV-GBM-1 trial appeared first on Drug Development Technology.
Can Blockchain Technology and Artificial Intelligence Cure What Ails Biomedical Research and Healthcare Curator: Stephen J. Williams, Ph.D. In the efforts to reduce healthcare costs, provide increased accessibility of service for patients, and drive biomedical innovations, many healthcare and biotechnology professionals have looked to advances in digital technology to determine the utility of IT t...
ArticleThe University of Arizona’s Biomedical Sciences Partnership Building serves a unique mission.
Alliqua BioMedical (Nasdaq:ALQA) and Adynxx a privately held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of Adynxx would become the majority owners of Alliqua’s outstanding common stock on a fully-diluted basis. As quoted in the press release: The proposed merger will create a public clinical-stage … Cont...
Medovex is buying the pulmonary biomedical services and patient delivery platform of biomedical services firm Regenerative Me -More-
The National Institute of Health (NIH) awarded $6.5m to a consortium of universities to create the Center for Reproducible Biomedical Modeling.
IBBL (Integrated BioBank of Luxembourg) announces the launch of Findmyassay.com, a new online tool allowing scientists to check the quality of their biological samples and improve the reproducibility of their biomedical research.
NewsResearchers have developed a tool that speeds up the analysis and publication of biomedical data from many months or years to mere minutes.
(University of Pennsylvania School of Medicine) The Perelman School of Medicine at the University of Pennsylvania has received a $2 million gift from the Blavatnik Family Foundation to establish the Blavatnik Family Fellowship in Biomedical Research in the Penn Biomedical Graduate Studies (BGS) program.
Curasan und die Leader Biomedical B.V. haben eine Zusammenarbeit vereinbart. Die Kooperation beinhaltet einen Private-Label-Vertrag zur Vermarktung der Hyaluronsäure von Curasan zur Arthrosetherapi...
Edison Investment Research - Pharmaceutical & healthcare - International Stem Cell : International Stem Cell (ISCO) reported Q218 revenues of $3.0m, up 72.4% compared to Q217 mainly due to the biomedical business, which had quarterly revenues of $2.7m, up 103.1% compared to the same quarter last year. The operating profit of the biomedical business also increased substantially, up 139.6% to $1.1m....
Edison Investment Research - Mining - Entree Resources: Edison Investment Research is terminating coverage on Entrée Resources (ETG). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: CA29384J1030
ALBANY, New York, August 6, 2018 /PRNewswire/ -- According to a new market report published by Transparency Market Research titled "Biomedical Refrigerators and Freezers Market Read more...